INOInovio Pharmaceuticals Inc
INO
Inovio Pharmaceuticals Inc92,214
Mkt Cap
$78.07MVolume
19.93M52W High
$2.9852W Low
$1.07PE Ratio
-0.58INO Fundamentals
Price
$1.13Prev Close
$1.74Open
$1.3550D MA
$1.65Beta
1.22Avg. Volume
782,548.99EPS (Annual)
-$1.81P/B
3.24Rev/Employee
$583.42$32.44
Inovio (INO) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Inovio (INO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks·16h ago
INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK...
PR Newswire·1d ago
What's Behind The Drop In Inovio Pharmaceuticals Stock Today?
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares are tumbling Thursday after the company announced the pricing of a proposed public offering.read more...
Benzinga·2d ago
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio...
PR Newswire·2d ago
INOVIO Announces Pricing of $17.5 Million Public Offering
INOVIO Announces Pricing of $17.5 Million Public Offering INOVIO Announces Pricing of $17.5 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., April 2, 2026 PLYMOUTH MEETING, Pa., April 2...
PR Newswire·2d ago
INOVIO Announces Proposed Public Offering
INOVIO Announces Proposed Public Offering INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., April 1, 2026 PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO...
PR Newswire·2d ago
INOVIO to Participate in Upcoming Scientific Conference
INOVIO to Participate in Upcoming Scientific Conference INOVIO to Participate in Upcoming Scientific Conference PR Newswire PLYMOUTH MEETING, Pa., April 1, 2026 PLYMOUTH MEETING, Pa., April 1, 2026...
PR Newswire·3d ago
Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your Rights - INO
Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your Rights - INO Inovio Pharmaceuticals, Inc. Securities Fraud...
PR Newswire·3d ago
INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm
INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm INO Shareholder Alert: April 7, 2026 Lead Plaintiff...
PR Newswire·4d ago
INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities...
PR Newswire·5d ago
<
1
2
...
>